Bimagrumab (BYM338) 10mg
Bimagrumab is a human monoclonal antibody used to block signaling from TGF-β superfamily ligands, intended to increase lean mass and alter adipose biology.
- The description claims that Bimagrumab binds activin type II receptors and blocks signaling from multiple TGF-β superfamily ligands.
- The description claims that Bimagrumab is designed to increase lean mass and alter adipose biology.
Variants (1)
- Default Title — 7250.00 EUR — In stock
How AI sees this product
The more complete this product's details, the more confidently AI assistants can understand and recommend it.
66%